Lisa provides strategic counsel on complex patent issues to clients in the pharmaceutical, biopharmaceutical, biotechnology and chemistry sectors. She brings an in-depth knowledge and extensive experience to her work advising clients on patent protection, freedom to operate and invalidity of blockbuster drugs they aim to produce and distribute.
Lisa’s advice on the full spectrum of global intellectual property portfolio management includes patent prosecution, opposition and other post-grant proceedings, and diverse regulatory matters for the following areas:
- Small molecules and biologics
- Drug delivery and drug preparation methods
- Diagnostics and personalized medicine
- Physical and materials sciences
- Food science and nutrition
- Renewable/green chemistry
- Polymer chemistry
- Agricultural, ornamental, vegetable and tree breeding and development
Since 2001, Lisa has worked closely with in-house legal departments of global pharmaceutical firms regarding their patent development and enforcement strategies. In this partnership, she provides training to new in-house counsel and meets with scientists and other business development to anticipate and resolve a wide array of problems including navigation of U.S. Food and Drug Administration approval.
Lisa holds office hours at the various life science incubators in and around Rockville, Maryland. Along with a rotating group of Michael Best lawyers, she confers with entrepreneurs, venture capitalists and scientists about their legal and regulatory concerns.
A thought leader on pharmaceutical and biopharmaceutical patent law, Lisa speaks frequently to legal and industry groups, and publishes widely. At Michael Best, she serves as Chair of the Life Sciences and Chemical Practices Group, and as a member of the Management Committee and the Venture Best® industry group. She is the author of an award-winning blog, BRIC Wall, which provides unique insights on patent law developments in the life sciences industry in Brazil, Russia, India and China.